Priscilla Merriam, MD
Senior Physician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Emanuele Mazzola, PhD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Ping Chi, MD, PhD (she/her/hers)
Member/Professor and Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Alice Chen, MD
Head, Developmental Therapeutics Clinic
Division of Cancer Treatment and Diagnosis, National Cancer Institute
Bethesda, Maryland, United States
Mark Agulnik, MD (he/him/his)
Sarcoma Section Chief
City of Hope, Department of Medical Oncology & Therapeutics Research
Duarte, California, United States
Melissa A. Burgess, MD (she/her/hers)
-
University of Pittsburgh Medical Center Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Scott M. Schuetze, MD, PhD
Clinical Professor of Internal Medicine
University of Michigan
Ann Arbor, Michigan, United States
Neeta Somaiah, MD (she/her/hers)
Associate Professor and Deputy Chair
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Brian Andrew Van Tine, MD, PhD (he/him/his)
Professor of Medicine
Washington University School of Medicine
St. Louis, Missouri, United States
Seth Pollack, MD
Sarcoma Program Director
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois, United States
Gabriel Tinoco, MD
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Jonathan Trent, MD, PhD
Professor of Medicine
Sylvester Comprehensive Cancer Center, University of Miami
Miami, Florida, United States
Breelyn A. Wilky, MD (she/her/hers)
Associate Professor
University of Colorado Cancer Center
Aurora, Colorado, United States
Nicola Bothwick, BA
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Richard Piekarz, MD, PhD
Division of Cancer Treatment and Diagnosis, National Cancer Institute
Bethesda, Maryland, United States
Matthew L. Hemming, MD, PhD
UMass Chan Medical School
Worcester, Massachusetts, United States
Bradley Bernstein, MD, PhD
Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School
Boston, Massachusetts, United States
Geoffrey I. Shapiro, MD, PhD
Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School
Boston, Massachusetts, United States
George Demetri, MD (he/him/his)
Professor and Senior Vice President of Experimental Therapeutics
Dana-Farber Cancer Institute, Ludwig Center at Harvard Medical School
Boston, Massachusetts, United States
Suzanne George, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
